SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
-0.83%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.37B
AUM Growth
-$255M
(-9.7%)
Cap. Flow
-$204M
Cap. Flow
% of AUM
-8.61%
Top 10 Holdings %
Top 10 Hldgs %
37.16%
Holding
101
New
12
Increased
22
Reduced
25
Closed
29
Top Buys
| 1 |
Amazon
AMZN
|
$82.9M |
| 2 |
Meta Platforms (Facebook)
META
|
$67.6M |
| 3 |
Take-Two Interactive
TTWO
|
$58.4M |
| 4 |
Walt Disney
DIS
|
$54.3M |
| 5 |
ServiceNow
NOW
|
$48.6M |
Top Sells
| 1 |
Humana
HUM
|
$92.5M |
| 2 |
Centene
CNC
|
$68.3M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$63.9M |
| 4 |
Royalty Pharma
RPRX
|
$49.7M |
| 5 |
Viatris
VTRS
|
$40.6M |
Sector Composition
| 1 | Healthcare | 45.3% |
| 2 | Industrials | 13.84% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Communication Services | 11.08% |
| 5 | Technology | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arcellx
ACLX
$4B
| $42.2M | 1.75% |
2,249,533
-221,026
| -9% | -$4.15M |
|
|
ITCI
27
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $39.6M | 1.65% |
851,958
-486,742
| -36% | -$22.6M |
|
|
XYZ
28
Block, Inc.
XYZ
$46.2B
| $36.4M | 1.51% |
661,540
-18,136
| -3% | -$997K |
|
29
McKesson
MCK
$86B
| $35.6M | 1.48% |
104,850
+48
| +0% | +$16.3K |
|
30
ProKidney
PROK
$310M
| $28.8M | 1.19% |
+3,193,175
| New | +$28.8M |
|
31
Fulcrum Therapeutics
FULC
$372M
| $28.5M | 1.19% |
3,528,000
+172,376
| +5% | +$1.39M |
|
32
Kezar Life Sciences
KZR
$28M
| $28.2M | 1.17% |
327,552
-113,678
| -26% | -$9.79M |
|
33
Sutro Biopharma
STRO
$86.5M
| $27.9M | 1.16% |
5,020,000
+375,000
| +8% | +$2.08M |
|
34
Cogent Biosciences
COGT
$1.81B
| $27.8M | 1.15% |
1,862,600
+1,262,600
| +210% | +$18.8M |
|
|
KDNY
35
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $27.3M | 1.13% |
1,390,000
-394,200
| -22% | -$7.75M |
|
36
Agios Pharmaceuticals
AGIO
$2.1B
| $27.1M | 1.13% |
959,214
-1,362,586
| -59% | -$38.5M |
|
37
Insmed
INSM
$30.1B
| $26.5M | 1.1% |
1,230,800
-847,880
| -41% | -$18.3M |
|
38
EyePoint Pharmaceuticals
EYPT
$819M
| $25.6M | 1.06% |
3,233,597
+265,390
| +9% | +$2.1M |
|
39
KalVista Pharmaceuticals
KALV
$765M
| $24.8M | 1.03% |
1,707,100
-221,100
| -11% | -$3.21M |
|
|
MRNS
40
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $23.5M | 0.98% |
3,537,700
+26,869
| +0.8% | +$179K |
|
41
Prothena Corp
PRTA
$442M
| $19.2M | 0.8% |
+316,531
| New | +$19.2M |
|
42
GFL Environmental
GFL
$17.5B
| $19.1M | 0.79% |
753,818
-149,314
| -17% | -$3.78M |
|
43
Marriott International Class A Common Stock
MAR
$73B
| $18.9M | 0.78% |
134,800
-157,887
| -54% | -$22.1M |
|
|
PNT
44
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $18M | 0.75% |
2,330,902
-683,506
| -23% | -$5.28M |
|
45
Heron Therapeutics
HRTX
$202M
| $11.8M | 0.49% |
2,807,000
-444,048
| -14% | -$1.87M |
|
46
Eli Lilly
LLY
$666B
| $11.4M | 0.47% |
+35,200
| New | +$11.4M |
|
47
Legend Biotech
LEGN
$6.46B
| $11.2M | 0.46% |
+274,200
| New | +$11.2M |
|
48
PepGen
PEPG
$42M
| $10.7M | 0.45% |
1,180,984
-444
| -0% | -$4.03K |
|
|
AKLI
49
DELISTED
Akili, Inc. Common Stock
AKLI
| $8.19M | 0.34% |
+3,624,163
| New | +$8.19M |
|
50
Alvotech
ALVO
$2.51B
| $6.76M | 0.28% |
1,000,000
| – | – |
|